Colorectal cancer (CRC) remains the second leading cause of cancer deaths in the United States (US) (
1), despite the high survival rate from early treatment (
2). It is estimated that 136830 new cases of colorectal cancer will be recorded in 2014 in the US and 50310 of these cases will die from the disease (
3). Cancer of the colon and rectum affects both males and females equally, and the risk increases with age (
3,
4). Mortality from CRC can be reduced drastically by early detection and early treatment. The survival rate for colorectal cancer is very low at late diagnosis of the disease. Five-year survival rates as high as about 90% have been reported for tumors detected and removed before extension (
2). Evidence also indicates a reduction in the survival rate to about 70% for tumors which have already extended, and as low as 13% when metastasis has already occurred (
2). Decline in CRC mortality rates in the US has been attributed to early detection and surgical removal of the tumor before metastasis (
5). Early detection and early treatment are possible due to the availability of effective and relatively inexpensive CRC screening tests (
6). A clinical trial showed 33 and 43% reductions in incidence and mortality of CRC respectively as result of a single sigmoidoscopy screening of adults between 55 and 64 years (
7). In the US, CRC screening is covered by most health plans and there is a published guideline for CRC screening (
8). However, uptake of CRC screening is relatively low, and it is about 50% of those for whom the test is highly recommended (
9-
11). This calls for public health efforts to increase awareness, acceptance and uptake of CRC screening, especially for those with increased risk. Researching factors that promote CRC screening is therefore crucial for public health interventions. Reported predictors of CRC screening include age, educational level, income level, and health insurance status (
9,
12). These predictors are similar to predictors for other screening programs, such as mammography. It therefore raises questions about the low uptake of CRC compared to screening programs for other cancers. This calls for more investigation into predictors of CRC screening uptake to inform policy and intervention planning. Several studies exist on the relationship between mental health and attitudes towards health programs. The link between depression, alcohol and tobacco use; and screening uptake have also been investigated. However, studies have differed on their findings. A study investigated the influence of depression on other cancer screening among breast cancer survivors in Latino. An inverse association was observed between depression and CRC screening uptake (
13). A recent survey in Washington State in the US identified depression as a significant barrier to cervical cancer screening uptake (
14). This finding partly corroborated a previous observation made in Canada (
15). However, Kaida and co-workers (
15) observed that age played an important role in the relationship between depression and cervical cancer screening. In contrast, Kodl and co-workers observed a significant increase in CRC uptake among those with mental health diagnosis in a bivariate analysis (
16). However, inverse association was observed when they controlled for timing of diagnosis and outpatient visits. This observation suggests that depression affects screening indirectly. In the United Kingdom, it was observed that lower depression indirectly increases uptake of CRC screening through a better self-rated health (
17). These findings call for more investigation into the relationship between mental health and CRC screening to inform policy and intervention. Insomnia has been found to be common among cancer patients (
18). However, to the best of our knowledge, the relationship between insomnia and CRC screening uptake has not yet been evaluated. Again, racial differences in the influence of depression on CRC screening have not yet been evaluated.